News Focus
News Focus
Replies to #61206 on Biotech Values
icon url

oldberkeley

04/08/08 6:30 PM

#61207 RE: rstor1 #61206

>Heck, I read where the entire Icelandic currency was being shorted so that DeCode can't use the loan from the Icelandic people...

Uh, I give up: they think that shorting on the currency market means that you actually take that currency out of circulation?????

Icelandic currency? Don't they use the "cube"?
icon url

Biowatch

04/08/08 8:06 PM

#61210 RE: rstor1 #61206

>schizophrenia... is what this company is ALL about. Schizophrenia drugs are used for a lifetime.<

Only if they find one that works...
icon url

DewDiligence

04/01/09 5:13 AM

#75356 RE: rstor1 #61206

DCGN is nearing the end of the road:

http://finance.yahoo.com/news/deCODE-genetics-Announces-prnews-14804935.html

At December 31, 2008, the company had liquid funds available for operating activities, comprised of cash and cash equivalents together with current investments, of $3.7 million, compared to $64.2 million at December 31, 2007. In early 2009, the company sold its auction rate securities (ARS) for $11.0 million in cash which the company has been using to finance its operating activities. The company believes it has sufficient resources to sustain operations only into the second quarter of this year.

It’s already the second quarter.